DE60009296D1 - Substituierte purine-derivate als zell-adhäsionhemmer - Google Patents

Substituierte purine-derivate als zell-adhäsionhemmer

Info

Publication number
DE60009296D1
DE60009296D1 DE60009296T DE60009296T DE60009296D1 DE 60009296 D1 DE60009296 D1 DE 60009296D1 DE 60009296 T DE60009296 T DE 60009296T DE 60009296 T DE60009296 T DE 60009296T DE 60009296 D1 DE60009296 D1 DE 60009296D1
Authority
DE
Germany
Prior art keywords
cell adhesion
purine derivatives
substituted purine
adhesion inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60009296T
Other languages
English (en)
Other versions
DE60009296T2 (de
Inventor
Anuschirwan Peyman
Jochen Knolle
R Gadek
Jean-Francois Gourvest
Jean-Marie Ruxer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Genentech Inc
Original Assignee
Aventis Pharma Deutschland GmbH
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH, Genentech Inc filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of DE60009296D1 publication Critical patent/DE60009296D1/de
Publication of DE60009296T2 publication Critical patent/DE60009296T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60009296T 1999-07-02 2000-06-26 Substituierte purine-derivate als zell-adhäsionhemmer Expired - Fee Related DE60009296T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99112637A EP1065208A1 (de) 1999-07-02 1999-07-02 Substituierte Purin Derivate als Inhibitoren der Zell-Adhäsion
EP99112637 1999-07-02
PCT/EP2000/005921 WO2001002399A1 (en) 1999-07-02 2000-06-26 Substituted purine derivatives as inhibitors of cell adhesion

Publications (2)

Publication Number Publication Date
DE60009296D1 true DE60009296D1 (de) 2004-04-29
DE60009296T2 DE60009296T2 (de) 2005-05-25

Family

ID=8238483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009296T Expired - Fee Related DE60009296T2 (de) 1999-07-02 2000-06-26 Substituierte purine-derivate als zell-adhäsionhemmer

Country Status (30)

Country Link
US (1) US6747016B1 (de)
EP (2) EP1065208A1 (de)
JP (1) JP2003503497A (de)
KR (1) KR20020015997A (de)
CN (1) CN1171888C (de)
AR (1) AR034242A1 (de)
AT (1) ATE262528T1 (de)
AU (1) AU774382B2 (de)
BG (1) BG106229A (de)
BR (1) BR0012050A (de)
CA (1) CA2376673A1 (de)
CZ (1) CZ20014553A3 (de)
DE (1) DE60009296T2 (de)
EA (1) EA005372B1 (de)
EE (1) EE200100713A (de)
ES (1) ES2219353T3 (de)
HU (1) HUP0300183A3 (de)
IL (1) IL147245A0 (de)
MX (1) MXPA01013241A (de)
MY (1) MY122631A (de)
NO (1) NO20016403L (de)
NZ (1) NZ516095A (de)
PL (1) PL352281A1 (de)
SK (1) SK18792001A3 (de)
TR (1) TR200103858T2 (de)
TW (1) TWI229080B (de)
UA (1) UA72923C2 (de)
WO (1) WO2001002399A1 (de)
YU (1) YU89701A (de)
ZA (1) ZA200200017B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042655A1 (de) * 2000-08-31 2002-03-14 Aventis Pharma Gmbh Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion
FR2847254B1 (fr) 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
FR2870541B1 (fr) 2004-05-18 2006-07-14 Proskelia Sas Derives de pyrimidines antigonistes du recepteur de la vitronectine
WO2007089335A2 (en) * 2005-12-29 2007-08-09 Lexicon Pharmaceutical Inc. Multicyclic amino acid derivatives and methods of their use
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN107450106A (zh) * 2017-09-28 2017-12-08 北京小米移动软件有限公司 饮水安全提示方法、装置及智能水杯
BR112022022409A2 (pt) 2020-05-06 2023-02-07 Ajax Therapeutics Inc 6-heteroarilóxi benzimidazóis e azabenzimidazóis como inibidores de jak2
TW202241889A (zh) 2020-12-23 2022-11-01 美商雅捷可斯治療公司 作為ｊａｋ２抑制劑之６－雜芳基氧基苯并咪唑及氮雜苯并咪唑
AU2022388555A1 (en) 2021-11-09 2024-05-02 Ajax Therapeutics, Inc. 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2186720T3 (es) * 1994-05-27 2003-05-16 Merck & Co Inc Composiciones para inhibir la reabsorcion osea mediada por osteoclastos.
AU724191B2 (en) * 1996-08-29 2000-09-14 Merck & Co., Inc. Integrin antagonists
EP0946164A4 (de) * 1996-10-30 2000-08-23 Merck & Co Inc Integrin antagonisten
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
CA2277273C (en) * 1997-01-17 2008-03-25 Merck & Co., Inc. Integrin antagonists
ID26219A (id) * 1998-01-23 2000-12-07 Aventis Pharma Gmbh Turunan-turunan sulfonamida baru sebagai penghambat-penghambat resorpsi tulang dan adhesi tulang
AU2610099A (en) 1998-01-28 1999-08-16 Danmist Aps Method of piezoelectrically atomising and pumping fluids and piezoelectric fluidatomising and pumping device

Also Published As

Publication number Publication date
NO20016403D0 (no) 2001-12-28
ES2219353T3 (es) 2004-12-01
CZ20014553A3 (cs) 2002-06-12
TWI229080B (en) 2005-03-11
EP1196416A1 (de) 2002-04-17
WO2001002399A1 (en) 2001-01-11
MY122631A (en) 2006-04-29
AR034242A1 (es) 2004-02-18
PL352281A1 (en) 2003-08-11
ZA200200017B (en) 2003-01-02
EP1065208A1 (de) 2001-01-03
HUP0300183A3 (en) 2005-12-28
AU5534900A (en) 2001-01-22
DE60009296T2 (de) 2005-05-25
CN1171888C (zh) 2004-10-20
UA72923C2 (uk) 2005-05-16
KR20020015997A (ko) 2002-03-02
EE200100713A (et) 2003-04-15
BG106229A (bg) 2002-08-30
EA200200121A1 (ru) 2002-06-27
NO20016403L (no) 2002-03-01
JP2003503497A (ja) 2003-01-28
US6747016B1 (en) 2004-06-08
HUP0300183A2 (hu) 2003-06-28
EP1196416B1 (de) 2004-03-24
BR0012050A (pt) 2002-12-31
YU89701A (sh) 2004-09-03
MXPA01013241A (es) 2002-06-21
EA005372B1 (ru) 2005-02-24
SK18792001A3 (sk) 2002-07-02
TR200103858T2 (tr) 2002-06-21
AU774382B2 (en) 2004-06-24
IL147245A0 (en) 2002-08-14
ATE262528T1 (de) 2004-04-15
NZ516095A (en) 2004-08-27
CN1371376A (zh) 2002-09-25
CA2376673A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
DE60026861D1 (de) Purin-derivate
DE60002356D1 (de) Purin-derivate
NO20016109L (no) Purinderivater
DE60008527D1 (de) Zellproliferation inhibitoren
ATE292140T1 (de) N6 heterocyclische 8-modifizierte adenosinderivate
FI951001A0 (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
AU5152100A (en) Substituted beta-alanine derivatives as cell adhesion inhibitors
ATE339403T1 (de) Pyrrolderivate als phosphodiesterase vii-hemmer
ATE236157T1 (de) Imidazopyridinderivate als phosphodiesterase vii- hemmer
ATE269349T1 (de) Derivativen von monosacchariden als zelladhäsionshemmer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
DE60009296D1 (de) Substituierte purine-derivate als zell-adhäsionhemmer
DK1147119T3 (da) 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer
DK1222193T3 (da) Imidazolderivater som phosphodiesterase VII-inhibitorer
ATE262517T1 (de) Thiopyranderivate as mmp-inhibitoren
TR200002831A3 (tr) Kinolin-4-Il türevleri I
FI951002A0 (fi) Sulfatoituja beta-glykolipidijohdannaisia soluadheesioinhibiittoreina
NO20022776L (no) Substituerte bisindolylmaleimider for inhibering av celleproliferasjon
DK1307455T3 (da) Inhibitorer af alpha-L-beta-2-medieret celleadhæsion
GB9804400D0 (en) Substituted pyrrole derivatives as cell adhesion inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee